Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients

Cisplatin-containing chemotherapy represents the first-line treatment for patients with locally advanced or metastatic muscle-invasive bladder cancer. Recently, novel therapies have become available for cisplatin-ineligible or -resistant patients. Therefore, prediction of cisplatin response is requi...

Descripción completa

Detalles Bibliográficos
Autores principales: Olah, Csilla, Tschirdewahn, Stephan, Hoffmann, Michèle J., Krafft, Ulrich, Hadaschik, Boris, Nyirady, Peter, Szendröi, Attila, Módos, Orsolya, Csizmarik, Anita, Kovalszky, Ilona, Reis, Henning, Szarvas, Tibor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690724/
https://www.ncbi.nlm.nih.gov/pubmed/33114033
http://dx.doi.org/10.3390/diagnostics10110864

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690724/
https://www.ncbi.nlm.nih.gov/pubmed/33114033
http://dx.doi.org/10.3390/diagnostics10110864

Ejemplares similares